Effect of short course enhanced external counterpulsation on the incidence of contrast nephropathy after phlebography

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100051516

Enrollment

Unknown

Registered

2021-09-25

Start date

2021-09-27

Completion date

Unknown

Last updated

2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

contrast-induced nephropathy

Interventions

Experimental group:Short course enhanced external counterpulsation

Control group:No

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years old; 2. There is a need for CTA examination to assist in diagnosis and treatment; 3. Those who did not use drugs or treatments that affect renal function 1 week before the CTA examination.

Exclusion criteria

Exclusion criteria: 1. Contraindications of CTA: contrast agent allergy, severe hepatic insufficiency, pregnant or breastfeeding women; 2. EECP contraindications: acute myocardial infarction, acute heart failure, severe aortic insufficiency, hypertrophic obstructive cardiomyopathy, malignant tumor with high possibility of metastasis, malignant arrhythmia with hemodynamic instability, pregnancy or breastfeeding women.

Design outcomes

Primary

Measure	Time frame
Serum creatinine;	—

Countries

China

Contacts

Public ContactQian Xiaoxian

The Third Affiliated Hospital of Sun-Yat-Sen University

qianxx@mail.sysu.edu.cn+86 18922102808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026